Blood isoflavone levels during intake of a controlled hospital diet

Journal of Nutritional Science and Vitaminology

Volumn 50, Issue 4, 2004, Pages 246-252

  Takashima, Naomi ^a   Miyanaga, Naoto ^a   Komiya, Kimitoshi ^b   Mori, Mitsuru ^c   Akaza, Hideyuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

^c SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Daidzein; Equol producer; Genistein; Hospital diet; Isoflavone

Indexed keywords

DAIDZEIN; EQUOL; GENISTEIN; ISOFLAVONE;

ADULT; AGED; ARTICLE; BLOMIA; BLOOD SAMPLING; CANCER PREVENTION; CORRELATION ANALYSIS; DIETARY INTAKE; EVALUATION; FOOD COMPOSITION; HOSPITAL FOOD SERVICE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; SOYBEAN;

BLOMIA; GLYCINE MAX;

EID: 4644356392     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.50.246     Document Type: Article

References (26)

1. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. 1991. Dietary effects on breast-cancer risk in Singapore. Lancet 337: 1197-1200.
2. Severson RK, Nomura AM, Grove JS, Stemmermann GN. 1989. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 49: 1857-1860.
3. Goodman MT, Hankin JH, Wilkens LR, Lyu LC, McDuffie K, Liu LQ, Kolonel LN. 1997. Diet, body size, physical activity, and the risk of endometrial cancer. Cancer Res 57: 5077-5085.
4. Evans BA, Griffiths K, Morton MS. 1995. Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol 147: 295-302.
5. Munro IC, Harwood M, Hlywka JJ, Stephen AM, Doull J, Flamm WG, Adlercreutz H. 2003. Soy isoflavones: a safety review. Nutr Rev 61: 1-33.
6. Makela S, Poutanen M, Kostian ML, Lehtimaki N, Strauss L, Santti R, Vihko R. 1998. Inhibition of 17beta-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells. Proc Soc Exp Biol Med 217: 310-316.
7. Peterson G, Barnes S. 1993. Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate 22: 335-345.
8. Molteni A, Brizio-Molteni L, Persky V. 1995. In vitro hormonal effects of soybean isoflavones. J Nutr 125: 751S-756S.
9. Akaza H, Miyanaga N, Takashima N. Naito S, Hirao Y, Tsukamoto T, Mori M. 2002. Is daidzein non-metabolizer a high risk for prostate cancer? A case-controlled study of serum soybean isoflavone concentration. Jpn J Clin Oncol 32: 296-300.
10. Slavin JL, Karr SC, Hutchins AM, Lampe JW. 1998. Influence of soybean processing, habitual diet, and soy dose on urinary isoflavonoid excretion. Am J Clin Nutr 68: 1492S-1495S.
11. Breinholt V, Larsen JC. 1998. Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF 7 cell proliferation assay. Chem Res Toxicol 11: 622-629.
12. Thompson FE, Byers T. 1994. Dietary assessment resource manual. J Nutr 124: 2245S-2317S.
13. Kimira M, Arai Y, Shimoi K, Watanabe S. 1998. Japanese intake of flavonoids and isoflavonoids from foods. J Epidemiol 8: 168-175.
14. Coward L, Kirk M, Albin N, Barnes S. 1996. Analysis of plasma isoflavones by reversed-phase HPLC-multiple reaction ion monitoring-mass spectrometry. Clin Chim Acta 247: 121-142.
15. Arai Y, Uehara M, Sato Y, Kimira M, Eboshida A, Adlercreutz H, Watanabe S. 2000. Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol 10: 127-135.
16. Yamamoto S, Sobue T, Sasaki S, Kobayashi M, Arai Y, Uehara M, Adlercreutz H, Watanabe S, Takahashi T, Iitoi Y, Iwase Y, Akabane M. Tsugane S. 2001. Validity and reproducibility of a self-administered food-frequency questionnaire to assess isoflavone intake in a Japanese population in comparison with dietary records and blood and urine isoflavones. J Nutr 131: 2741-2747.
17. Wakai K, Egami I, Kato K, Kawamura T, Tamakoshi A. Lin Y, Nakayama T, Wada M, Ohno Y. 1999. Dietary intake and sources of isoflavones among Japanese. Nutr Cancer 33: 139-145.
18. Adlercreutz H, Honjo H, Higashi A, Fotsis T. Hamalainen E, Hasegawa T, Okada H. 1991. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr 54: 1093-1100.
19. Xu X, Wang HJ, Murphy PA, Cook L, Hendrich S. 1994. Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 124: 825-832.
20. Watanabe S, Yamaguchi M, Sobue T, Takahashi T, Miura T, Arai Y Mazur W, Wahala K, Adlercreutz H. 1998. Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J Nutr 128: 1710-1715.
21. Fukui Y, Nasada M, Toda T, Okuhira T, Hayashi A. 1999. Influence of soy isoflavones in Japanese men. Kenkou Eiyo Syokuhin Kenkyu 2: 63-71 (in Japanese).
22. Kenko Eiyo Joho Kenkyukai. 2003. Kokumin Eiyo no Genjyo 2000. Daiichi Shuppan, Tokyo (in Japanese).
23. Colditz GA, Frazier AL. 1995. Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol Biomarkers Prev 4: 567-571.
24. Tominaga H, Oshima A, Kuroiwa T. 1999. Gann-Toukei Hakusyo-1999. Shinohara Shuppan Sinsha, Tokyo (in Japanese).
25. King RA, Bursill DB. 1998. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am J Clin Nutr 67: 867-872.
26. Kinjo J. 2000. Phytoestrogens. Nippon Rinsho 58: 2434-2438 (in Japanese).